Following the approval of the new CF drug Orkambi, we sat down with Dr. Mike Boyle, our new vice president of therapeutics development, to learn more about the future of clinical research and what's most exciting.
The CF Foundation is focused on bringing forward new therapies to help people with CF enjoy the best health and quality of life.
This site contains general information about cystic fibrosis, as well as personal insight from the CF community. Opinions and experiences shared by members of our community, including but not limited to people with CF and their families, belong solely to the blog post author and do not represent those of the Cystic Fibrosis Foundation, unless explicitly stated. In addition, the site is not intended as a substitute for treatment advice from a medical professional. Consult your doctor before making any changes to your treatment.